Latvia IVD Market by Technology Molecular Diagnostics (Hepatitis C, Hepatitis B, Human Immunodeficiency Virus (HIV), Cytomegalovirus (CMV), Epstein–Barr virus (EBV), Tuberculosis, Sexually Transmitted Diseases (STDs), Hospital Acquired Infections, Respiratory Infections, Human Papillomavirus (HPV), Covid- 19), Tissue Diagnostics (H&E Stains, Special Stains, Advanced Stains, Digital Scanners), Sequencing (Clinical, NIPT and Research Use Only) Geography (Latvia,), and forecast to 2029

Latvia IVD market Dynamics

In Latvia, high growth areas in infectious diseases are HPV, STDs, Respiratory Infections, Hospital Acquired Infection (HAIs), Oncology Markers. Human Papillomavirus (HPV) is most common cause of cervical cancer but most HPV-infected women do not develop cervical cancer. In 2021, Latvia HPV test value accounted for 21.8 thousand Euro and expected to reach 748.2 thousand Euro in 2029. Respiratory Infection is one of the most common infections among humans and is the main cause of mortality of children up to five years of age. Polymerase chain reaction (PCR), a molecular approach recently adopted in diagnostic laboratories, aids in the reasonably reliable diagnosis of M.pneumoniae and C.pneumoniae. Latvia has a high rate of hospitalizations for asthma, which is more than double the EU average (119 per 100 000 population versus 52 per 100 000 population). Death rates from respiratory diseases are on average 85% higher among men than among women in all EU countries. Human Bocavirus 1 (HBoV1) is one of the respiratory infections detected in Latvia and that the co-infection rate among HBoV1-positive cases is up to 90%. The most commonly detected co-infections with HBoV1 were HRV (37.50%), Adv. (35.42%), RSV A (29.17%), RSV B(20.83%), MPV (10.42%) and HEV (10.42%). In 2021, respiratory infections accounted for 308.8 thousand Euros and expected to reach 310.8 thousand Euros by 2029. Hospital-acquired infections (HAI) are gradually increasing in Latvia due to rise in a number of hospital admissions and grow in number of surgical procedures. Amongst the commonly isolated HAIs, gram-negative bacteria (GNBs) are of particular concern, especially given the significantly higher rate of associated complications. Among all the species, Escherichia spp., Klebsiella spp., and Acinetobacter spp. are most commonly observed infections in Latvia. E. coli contributed the around 35% of infections followed by Kebsiella spp. With 20% and Acinetobacter spp. With around 10%. Together, these three genera accounted for more than 60% of the total isolates. In 2021, Hospital acquired infection accounted for the market value of 923.7 thousand Euros and expected to reach 1.2 Mn Euros by 2029.